Ligand profile
ZINC10146611
Virtual-screening candidate from ZINC.
Bound to: VK055_3495 — pantetheine-phosphate adenylyltransferase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC10146611- UniProt (similar protein)
P0A6I6- Tanimoto
- 0.725
- Target protein
- VK055_3495
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 54.1
- −1 ≤ LogP ≤ 5 4.45
- MW ≤ 500 Da 350.5
- LogP ≤ 5 4.45
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 2
- Rotatable bonds ≤ 10 5
- TPSA ≤ 140 Ų 54.1
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
COc1ccc2[nH]cc(CCNC(=O)c3ccc(C(C)(C)C)cc3)c2c1COc1ccc2[nH]cc(CCNC(=O)c3ccc(C(C)(C)C)cc3)c2c1
InChI=1S/C22H26N2O2/c1-22(2,3)17-7-5-15(6-8-17)21(25)23-12-11-16-14-24-20-10-9-18(26-4)13-19(16)20/h5-10,13-14,24H,11-12H2,1-4H3,(H,23,25)InChI=1S/C22H26N2O2/c1-22(2,3)17-7-5-15(6-8-17)21(25)23-12-11-16-14-24-20-10-9-18(26-4)13-19(16)20/h5-10,13-14,24H,11-12H2,1-4H3,(H,23,25)
WWXULOIIRFXFHQ-UHFFFAOYSA-NWWXULOIIRFXFHQ-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- F1V
- Homolog
- P0A6I6
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC10146611 →
- ZINC ZINC20 ZINC10146611 →
- UniProt UniProt P0A6I6 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC10146611”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_3495.
PDB 22
Ligands co-crystallized with this protein (structural evidence).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).